Sohini Das &Amp;Amp; Deepak Patel

Stories by Sohini Das &Amp;Amp; Deepak Patel

Closed since Balakot strike, Pak reopens airspace to civilian flights

Closed since Balakot strike, Pak reopens airspace to civilian flights

Rediff.com   16 Jul 2019

The move is expected to give a major relief to Air India, which suffered a huge financial loss of around Rs 491 crore.

Safety lapses: DGCA issues notices to 4 IndiGo executives

Safety lapses: DGCA issues notices to 4 IndiGo executives

Rediff.com   12 Jul 2019

The DGCA is conducting special audit of all airlines and airports which are in monsoon-affected areas in the wake of multiple landing incidents across the country.

India's rural mobile phone base slips further

India's rural mobile phone base slips further

Rediff.com   26 Jun 2019

According to telcos and analysts, this is due to SIM consolidation happening after the minimum recharge plans were implemented by incumbents.

Despite cap on pricing import of medical devices rises

Despite cap on pricing import of medical devices rises

Rediff.com   24 Jun 2019

The growth in imports was led by product categories such as diagnostic items, ultra-sonogram machines, MRI and ECG apparatus, syringes with needles, suture needles, digital thermometers, malaria diagnostic kits, and hearing aids.

Why telcos have little interest in 5G auctions

Why telcos have little interest in 5G auctions

Rediff.com   17 Jun 2019

Bharti Airtel called the prices exorbitant while Vodafone Idea wants the auctions take place in 2020. The auctions need to happen when the infrastructure is ready for the roll out, be it in terms of fiberisation levels, or optimisation of equipment and software etc. Spending a hefty amount on a technology (airwaves) that at present offers limited returns is not going to be a priority for the incumbent telcos.

Mobile user base suffers biggest fall since April 2018

Mobile user base suffers biggest fall since April 2018

Rediff.com   22 May 2019

Mukesh Ambani's Reliance Jio, however, continued to add wireless subscribers

2 reasons why drug sales are in poor health

2 reasons why drug sales are in poor health

Rediff.com   11 May 2019

Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind poor sales.

How Saridon has managed to remain top of the mind

How Saridon has managed to remain top of the mind

Rediff.com   3 May 2019

What has worked though for Brand Saridon has been its single-minded focus on headaches as opposed to other analgesics that dwell on a wider set of problems, reports Sohini Das.

Can Vodafone Idea reap synergy benefits?

Can Vodafone Idea reap synergy benefits?

Rediff.com   23 Apr 2019

India's largest telecom operator in terms of subscriber numbers has been struggling to raise its share of subscribers in the market for fourth-generation technology services.

MNC pharma cos may be afflicted by pneumonia virus

MNC pharma cos may be afflicted by pneumonia virus

Rediff.com   22 Apr 2019

Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.

Why Jio may now have to buy spectrum from the open market

Why Jio may now have to buy spectrum from the open market

Rediff.com   20 Apr 2019

While the company insisted it had enough spectrum across circles, analysts said the company might soon need to acquire some spectrum to ensure uninterrupted service.

Raymond forays into real estate with Thane project

Raymond forays into real estate with Thane project

Rediff.com   4 Apr 2019

The project will house 3,000 residential units across 10 towers in the first phase on a 20-acre land parcel that Raymond owns in Thane

India may ban Boeing 737 Max 8 planes, decision likely on Wednesday

India may ban Boeing 737 Max 8 planes, decision likely on Wednesday

Rediff.com   12 Mar 2019

About 350 Boeing 737 Max 8 are currently in service with airlines around the world, with thousands more on order. Boeing insists it has no reason to pull the popular aircraft from the skies.

Why cold wave across US is good news for Indian drug cos

Why cold wave across US is good news for Indian drug cos

Rediff.com   12 Mar 2019

Companies such as Cadila Healthcare, Lupin, and Natco, which sell generic versions of flu medication in the US market, are likely to benefit.

Jet's woes deepen, 49 out of 119 aircraft grounded

Jet's woes deepen, 49 out of 119 aircraft grounded

Rediff.com   7 Mar 2019

DGCA has told the airline that only "air worthy" aircraft, which are completely fit for flying, should be used in operations.

Jio likely to grab 51% revenue market share in 3 years

Jio likely to grab 51% revenue market share in 3 years

Rediff.com   7 Jan 2019

Airtel and Vodafone Idea are also trying to expand the penetration of 4G users in their subscriber base as they take this network to the hinterland

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com   6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Rediff.com   9 Nov 2018

Singh, who was instrumental in building required capabilities in the organisation said his role at Fortis did not allow him to spend time with his family, as the reason behind his resignation.

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com   1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga

Why drug firms' Q2 revenue growth is likely to dip

Why drug firms' Q2 revenue growth is likely to dip

Rediff.com   12 Oct 2018

Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.